Stock screener

PACB

Conviction 3IndustrialsScan · Mon, Aug 10, 2026
PACB$1.15-3.38%
ResistanceSupportVol 14
63 bars
Vol MA14 7.27M
May 11May 28Jun 16Jul 6Jul 23Aug 10
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.LABORATORY ANALYTICAL INSTRUMENTSwww.pacb.com
Price1.15
Change-3.38%
Gap-1.27%
Rel volume1.14×
Avg volume6.89M
Avg $ vol9.28M
SMA 201.38
SMA 501.45
SMA 2001.69
Price vs 50-21.12%
Price vs 200-32.38%
MA stackbearish
50/200 cross
Supertrenddown · 1.45
RSI (14)33
MACD hist-0.03
MACD cross
Stoch %K / %D7 / 7
ADX (14)17
+DI / −DI12 / 31
RSI divergence
MACD divergence
ATR %+8.75%
ADR %6.44%
52w high2.67
52w low1.12
From 52w high-57.12%
Above 52w low+2.23%
New 52w highNo
SqueezeOff
Bollinger width30.21%
%B-0.06
Donchian pos5.81%
Donchian high1.55
Donchian low1.12
AVWAP (52w high)1.55
vs AVWAP high-25.90%
AVWAP (52w low)1.43
vs AVWAP low-20.05%
OBV trendFlat
Chaikin MF (20)-0.28
Today vs 20d1.14×
Avg vol (14d)7.27M
Avg vol (20d)6.89M
Avg $ vol (20d)9.28M
Market cap
RS 3m (vs SPY)-33.88%
RS 6m (vs SPY)-45.02%
RS line new highNo
Trend template0/8
Technical rank6.8
1 week-19.37%
1 month-26.60%
3 months-18.79%
6 months-37.09%
1 year-9.13%
YTD-37.77%
P/E-0.67
P/B-11.04
P/S4.66
P/FCF-3.22
EPS-1.82
Div yield
ROE
ROA-72.67%
Debt/Eq-0.41
Current4.92
EV/EBITDA-0.58
Gross margin58.23%
Net margin-694.90%
Rev growth-15.88%
EPS growth-76.34%
Price target2.38
Target upside101.69%
Analyst ratingBuy
Institutional69.30%
Ent. value319.31M
Revenue39.01M
Net income-44.74M
Gross profit12.64M
Free cash flow-113.92M
IndustryLABORATORY ANALYTICAL INSTRUMENTS
ExchangeNasdaq
Shares out
Employees485
ListedWed, Oct 27, 2010
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction3 / 100
Pattern quality
Tech rank6.8 / 100
Group rank68 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance1.76
Support1.31
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PACB

All disclosures →
No recent disclosed trades by Congress in PACB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PACB · 10 buys

InsiderSideShares
Ericson William W.
Director · Stock Option (right to buy) · 2026-06-03
Grant223.49K
LIVINGSTON RANDALL S
Director · Stock Option (right to buy) · 2026-06-03
Grant223.49K
Smith Christopher M
Director · Stock Option (right to buy) · 2026-06-03
Grant223.49K
MOHR MARSHALL
Director · Stock Option (right to buy) · 2026-06-03
Grant223.49K
Gibson Christopher
Director · Stock Option (right to buy) · 2026-06-03
Grant74.5K
ORDONEZ KATHY
Director · Stock Option (right to buy) · 2026-06-03
Grant223.49K
MILLIGAN JOHN F
Director · Stock Option (right to buy) · 2026-06-03
Grant223.49K
Valantine Hannah
Director · Stock Option (right to buy) · 2026-06-03
Grant223.49K
Gibson Christopher
Director · Common Stock · 2026-04-08
Grant57.47K
Gibson Christopher
Director · Stock Option (right to buy) · 2026-04-08
Grant77.84K

SEC filings

EDGAR filings in PACB · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.